Editor–Akinsanya and colleagues (Clin Med June 2009 pp 239–41) pertinently discuss the
course to be taken when a patient with acute stroke may not be capable of consenting to …

When I testify on behalf of an emergency physician accused of medical negligence simply
because he or she did not use thrombolytic therapy in a patient with acute ischemic stroke …

Background Thrombolytic therapy for acute ischemic stroke raises several unsettled
bioethical issues related to risk versus benefit. Excluding the National Institutes of …

Editor—Chantler and Johnson suggested that patients should receive copies of letters and
summaries. 1 We have researched this subject in our practice since 1998. 2 Our experience …

“consistent with reported trial data” means they were also consistent with a worse outcome,
although confidence intervals are not presented. Thrombolysis with tPA is not endorsed as a …

There is a broad range of responses to any new treatment, especially when overall positive
results are accompanied by substantial risks. What is more surprising to me than the apathy …

Editors' Note: This month we continue the new feature-STEPped Care: An Evidence-
BasedApproach to Drug Therapy. These articles are designed to provide concise answers to …

A paper that changed my practice: which tugboat turned the Queen Mary? My immediate
thoughts revolve around such issues as the nature of my practice and any really dramatic …

Thrombolytic therapy for acute ischaemic stroke (AIS), like all other therapies, is associated
with both risks and benefits, and it is the balance between the two that determines the …

Life is short, and Art long; the crisis fleeting; experience perilous, and decision difficult. The
physician must not only be prepared to do what is right himself, but also to make the patient …